Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall E Cates

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of the American Geriatrics Society|February 8, 2006
Facts about atypical antipsychoticsMarshall E Cates
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 26, 2003
Ziprasidone--not an option for serotonin syndromeMarshall E Cates
The Mental Health Clinician|February 4, 2022
Istradefylline: A novel agent in the treatment of "off" episodes associated with levodopa/carbidopa use in Parkinson diseaseLauren Cummins, Marshall E Cates
The Mental Health Clinician|June 30, 2018
Effects of a psychiatric clinical rotation on pharmacy students' attitudes toward mental illness and the provision of pharmaceutical care to the mentally illMarshall E Cates, Thomas W Woolley
Journal of American College Health : J of ACH|August 4, 2012
Experience with a drug screening program at a school of pharmacyMarshall E Cates, Michael D Hogue
The Mental Health Clinician|May 9, 2022
Ambitious AAPP vision necessitates bold actionsMarshall E Cates, Cherry W Jackson
The Annals of Pharmacotherapy|December 9, 2004
The role of venlafaxine in the treatment of obsessive-compulsive disorderNicole J Phelps, Marshall E Cates
Crisis|July 28, 2018
The Association Between Lithium in Drinking Water and Incidence of Suicide Across 15 Alabama CountiesAnna Palmer, Marshall E Cates, Greg Gorman
American Journal of Pharmaceutical Education|March 12, 2010
Peer evaluations can be problematicMarshall E Cates, Mary R Monk-Tutor
The Annals of Pharmacotherapy|March 8, 2012
Pregabalin for the treatment of generalized anxiety disorderTerri M Wensel, Krystal W Powe, Marshall E Cates
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of the American Geriatrics Society|February 8, 2006
Facts about atypical antipsychoticsMarshall E Cates
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 26, 2003
Ziprasidone--not an option for serotonin syndromeMarshall E Cates
The Mental Health Clinician|February 4, 2022
Istradefylline: A novel agent in the treatment of "off" episodes associated with levodopa/carbidopa use in Parkinson diseaseLauren Cummins, Marshall E Cates
The Mental Health Clinician|June 30, 2018
Effects of a psychiatric clinical rotation on pharmacy students' attitudes toward mental illness and the provision of pharmaceutical care to the mentally illMarshall E Cates, Thomas W Woolley
Journal of American College Health : J of ACH|August 4, 2012
Experience with a drug screening program at a school of pharmacyMarshall E Cates, Michael D Hogue
The Mental Health Clinician|May 9, 2022
Ambitious AAPP vision necessitates bold actionsMarshall E Cates, Cherry W Jackson
The Annals of Pharmacotherapy|December 9, 2004
The role of venlafaxine in the treatment of obsessive-compulsive disorderNicole J Phelps, Marshall E Cates
Crisis|July 28, 2018
The Association Between Lithium in Drinking Water and Incidence of Suicide Across 15 Alabama CountiesAnna Palmer, Marshall E Cates, Greg Gorman
American Journal of Pharmaceutical Education|March 12, 2010
Peer evaluations can be problematicMarshall E Cates, Mary R Monk-Tutor
The Annals of Pharmacotherapy|March 8, 2012
Pregabalin for the treatment of generalized anxiety disorderTerri M Wensel, Krystal W Powe, Marshall E Cates
Pageof 4